Latest News in the pharma Industry

All

First patients treated in Phase I/II trial of  NOX-A12 combined with Keytruda in metastatic pancreatic and colorectal cancer

First patients treated in Phase I/II trial of NOX-A12 combined with Keytruda in metastatic pancreatic and colorectal cancer

4 Jul 2017

NOX-A12 has the potential to transform cancer types that are resistant to checkpoint inhibitor therapy into checkpoint inhibitor sensitive tumours

Read more 
Sun Pharma & Samsung BioLogics announce strategic manufacturing tie-up for Tildrakizumab

Sun Pharma & Samsung BioLogics announce strategic manufacturing tie-up for Tildrakizumab

4 Jul 2017

Tildrakizumab is an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe plaque psoriasis.

Read more 
Idifarma approved for EU-GMP commercial capsule manufacturing

Idifarma approved for EU-GMP commercial capsule manufacturing

3 Jul 2017

Idifarma, a Spanish CDMO, has expanded its GMP manufacturing offering with the installation of new automatic capsule filling capabilities at its EU-GMP approved plant in Pamplona, Spain.

Read more 
Common antimicrobials help patients recover from MRSA abscesses

Common antimicrobials help patients recover from MRSA abscesses

3 Jul 2017

NIAID-funded trial counters current thinking about treatment effectiveness.

Read more 
Lilly's Olumiant gets the thumbs up in Japan for the treatment of rheumatoid arthritis

Lilly's Olumiant gets the thumbs up in Japan for the treatment of rheumatoid arthritis

3 Jul 2017

In clinical studies, baricitinib has demonstrated significant improvement in the signs and symptoms of RA compared to standard-of-care therapies.

Read more 
New second generation solvent evaporators from Biotage

New second generation solvent evaporators from Biotage

3 Jul 2017

Three new TurboVap evaporation systems increase laboratory reliability.

Read more 
FDA approves Vectibix for use in wild-type RAS metastatic colorectal cancer

FDA approves Vectibix for use in wild-type RAS metastatic colorectal cancer

2 Jul 2017

First-and-only fully human monoclonal anti-epidermal growth factor receptor antibody approved by the FDA for this patient population.

Read more 
Gyros Protein Technologies introduces new ADA solution for immunogenicity market

Gyros Protein Technologies introduces new ADA solution for immunogenicity market

2 Jul 2017

Developed to support assay development and validation for detection of anti-drug antibodies.

Read more 
Exscientia enters strategic drug discovery collaboration with GSK

Exscientia enters strategic drug discovery collaboration with GSK

2 Jul 2017

Pre-clinical collaboration focused on up to 10 targets nominated by GSK.

Read more 
Patheon to invest $45 million, expanding capabilities to support continued growth

Patheon to invest $45 million, expanding capabilities to support continued growth

2 Jul 2017

Investments in commercial and development spray drying, and flexible manufacturing solutions.

Read more 
Bioverativ completes acquisition of True North Therapeutics

Bioverativ completes acquisition of True North Therapeutics

29 Jun 2017

Strengthens leadership in rare blood disorders with first-in-class candidate to treat cold agglutinin disease, a chronic autoimmune hemolytic anemia with no approved therapies.

Read more 
First prostate cancer patients treated with Augmenix's SpaceOAR Hydrogel in Israel

First prostate cancer patients treated with Augmenix's SpaceOAR Hydrogel in Israel

29 Jun 2017

The Chaim Sheba Medical Center now offers the hydrogel spacer to reduce side-effects during prostate cancer radiation therapy.

Read more